These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16610779)

  • 1. Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening application.
    Cozza G; Bonvini P; Zorzi E; Poletto G; Pagano MA; Sarno S; Donella-Deana A; Zagotto G; Rosolen A; Pinna LA; Meggio F; Moro S
    J Med Chem; 2006 Apr; 49(8):2363-6. PubMed ID: 16610779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urolithin as a converging scaffold linking ellagic acid and coumarin analogues: design of potent protein kinase CK2 inhibitors.
    Cozza G; Gianoncelli A; Bonvini P; Zorzi E; Pasquale R; Rosolen A; Pinna LA; Meggio F; Zagotto G; Moro S
    ChemMedChem; 2011 Dec; 6(12):2273-86. PubMed ID: 21972104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: an integrate approach to elucidate the putative binding motif and explain structure-activity relationships.
    Chilin A; Battistutta R; Bortolato A; Cozza G; Zanatta S; Poletto G; Mazzorana M; Zagotto G; Uriarte E; Guiotto A; Pinna LA; Meggio F; Moro S
    J Med Chem; 2008 Feb; 51(4):752-9. PubMed ID: 18251491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid.
    Sekiguchi Y; Nakaniwa T; Kinoshita T; Nakanishi I; Kitaura K; Hirasawa A; Tsujimoto G; Tada T
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2920-3. PubMed ID: 19414254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.
    Pagano MA; Andrzejewska M; Ruzzene M; Sarno S; Cesaro L; Bain J; Elliott M; Meggio F; Kazimierczuk Z; Pinna LA
    J Med Chem; 2004 Dec; 47(25):6239-47. PubMed ID: 15566294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput docking.
    Vangrevelinghe E; Zimmermann K; Schoepfer J; Portmann R; Fabbro D; Furet P
    J Med Chem; 2003 Jun; 46(13):2656-62. PubMed ID: 12801229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of 3-carboxy-4(1H)-quinolones as inhibitors of human protein kinase CK2.
    Golub AG; Yakovenko OY; Bdzhola VG; Sapelkin VM; Zien P; Yarmoluk SM
    J Med Chem; 2006 Nov; 49(22):6443-50. PubMed ID: 17064064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase CK2 as a druggable target.
    Sarno S; Pinna LA
    Mol Biosyst; 2008 Sep; 4(9):889-94. PubMed ID: 18704226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of polyoxometalates as nanomolar noncompetitive inhibitors of protein kinase CK2.
    Prudent R; Moucadel V; Laudet B; Barette C; Lafanechère L; Hasenknopf B; Li J; Bareyt S; Lacôte E; Thorimbert S; Malacria M; Gouzerh P; Cochet C
    Chem Biol; 2008 Jul; 15(7):683-92. PubMed ID: 18635005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based design of novel potent protein kinase CK2 (CK2) inhibitors with phenyl-azole scaffolds.
    Hou Z; Nakanishi I; Kinoshita T; Takei Y; Yasue M; Misu R; Suzuki Y; Nakamura S; Kure T; Ohno H; Murata K; Kitaura K; Hirasawa A; Tsujimoto G; Oishi S; Fujii N
    J Med Chem; 2012 Mar; 55(6):2899-903. PubMed ID: 22339433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2.
    Pagano MA; Meggio F; Ruzzene M; Andrzejewska M; Kazimierczuk Z; Pinna LA
    Biochem Biophys Res Commun; 2004 Sep; 321(4):1040-4. PubMed ID: 15358133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of protein kinase CK2 inhibitors using solvent dipole ordering virtual screening.
    Nakanishi I; Murata K; Nagata N; Kurono M; Kinoshita T; Yasue M; Miyazaki T; Takei Y; Nakamura S; Sakurai A; Iwamoto N; Nishiwaki K; Nakaniwa T; Sekiguchi Y; Hirasawa A; Tsujimoto G; Kitaura K
    Eur J Med Chem; 2015; 96():396-404. PubMed ID: 25912672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazole.
    Battistutta R; Mazzorana M; Sarno S; Kazimierczuk Z; Zanotti G; Pinna LA
    Chem Biol; 2005 Nov; 12(11):1211-9. PubMed ID: 16298300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).
    Sarno S; de Moliner E; Ruzzene M; Pagano MA; Battistutta R; Bain J; Fabbro D; Schoepfer J; Elliott M; Furet P; Meggio F; Zanotti G; Pinna LA
    Biochem J; 2003 Sep; 374(Pt 3):639-46. PubMed ID: 12816539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
    López-Ramos M; Prudent R; Moucadel V; Sautel CF; Barette C; Lafanechère L; Mouawad L; Grierson D; Schmidt F; Florent JC; Filippakopoulos P; Bullock AN; Knapp S; Reiser JB; Cochet C
    FASEB J; 2010 Sep; 24(9):3171-85. PubMed ID: 20400536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effect and its kinetic analysis of baicalein on recombinant human protein kinase CK2 holoenzyme].
    Lin XC; Liu XG; Chen XW; Chen WZ; Liang NC
    Ai Zheng; 2004 Aug; 23(8):874-8. PubMed ID: 15301706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential glycogen kinase-3 inhibitors by structure based virtual screening.
    Dessalew N; Bharatam PV
    Biophys Chem; 2007 Jul; 128(2-3):165-75. PubMed ID: 17482749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel potent pyrimido[4,5-c]quinoline inhibitors of protein kinase CK2: SAR and preliminary assessment of their analgesic and anti-viral properties.
    Pierre F; O'Brien SE; Haddach M; Bourbon P; Schwaebe MK; Stefan E; Darjania L; Stansfield R; Ho C; Siddiqui-Jain A; Streiner N; Rice WG; Anderes K; Ryckman DM
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1687-91. PubMed ID: 21316963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2.
    Nie Z; Perretta C; Erickson P; Margosiak S; Almassy R; Lu J; Averill A; Yager KM; Chu S
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4191-5. PubMed ID: 17540560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of cyclin-dependent kinase inhibitor, CR229, using structurebased drug screening.
    Kim MK; Min J; Choi BY; Lim H; Cho YH; Lee CH
    J Microbiol Biotechnol; 2007 Oct; 17(10):1712-6. PubMed ID: 18156791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.